5:20 PM
 | 
Jan 12, 2012
 |  BC Extra  |  Company News

Bayer's Trudeau to lead Covidien spinout

Mark Trudeau is leaving Bayer AG (Xetra:BAYN) to become president of the pharmaceuticals business of Covidien plc (NYSE:COV). Covidien, which markets medical...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >